Evaluation of the relationship between Ki67 expression level and neoadjuvant treatment response and prognosis in breast cancer based on the Neo-Bioscore staging system

BACKGROUND: Neoadjuvant chemotherapy (NAC) is widely used in the treatment of primary breast cancer. Different staging systems have been developed to evaluate the residual tumor after NAC and classify patients into different prognostic groups. Ki67, a proliferation marker, has been shown to be usefu...

Descripción completa

Detalles Bibliográficos
Autores principales: Sullu, Yurdanur, Tomak, Leman, Demirag, Guzin, Kuru, Bekir, Ozen, Necati, Karagoz, Filiz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597910/
https://www.ncbi.nlm.nih.gov/pubmed/37875716
http://dx.doi.org/10.1007/s12672-023-00809-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597910/
https://www.ncbi.nlm.nih.gov/pubmed/37875716
http://dx.doi.org/10.1007/s12672-023-00809-w

Ejemplares similares